A detailed history of Neo Ivy Capital Management transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 1,384 shares of ZBH stock, worth $156,419. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,384
Holding current value
$156,419
% of portfolio
0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$104.47 - $116.17 $144,586 - $160,779
1,384 New
1,384 $149,000
Q3 2023

Nov 29, 2023

BUY
$110.76 - $143.18 $632,661 - $817,844
5,712 New
5,712 $641,000
Q2 2022

Aug 16, 2022

BUY
$102.23 - $133.85 $122,164 - $159,950
1,195 New
1,195 $125,000
Q4 2021

Feb 15, 2022

SELL
$115.43 - $146.63 $348,136 - $442,236
-3,016 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$136.35 - $158.76 $411,231 - $478,820
3,016 New
3,016 $360,000
Q2 2021

Aug 16, 2021

SELL
$152.95 - $173.41 $462,979 - $524,912
-3,027 Closed
0 $0
Q1 2021

Oct 07, 2021

BUY
$148.16 - $159.71 $448,480 - $483,442
3,027 New
3,027 $485,000
Q4 2020

Feb 16, 2021

SELL
$128.25 - $151.41 $139,407 - $164,582
-1,087 Closed
0 $0
Q3 2020

Nov 17, 2020

SELL
$113.59 - $141.68 $1.05 Million - $1.31 Million
-9,233 Reduced 89.47%
1,087 $147,000
Q2 2020

Aug 17, 2020

BUY
$87.02 - $133.4 $635,594 - $974,353
7,304 Added 242.18%
10,320 $1.2 Million
Q2 2020

Aug 17, 2020

BUY
$87.02 - $133.4 $262,452 - $402,334
3,016 New
3,016 $360,000
Q3 2019

Nov 21, 2019

SELL
$113.33 - $138.46 $1.17 Million - $1.43 Million
-10,320 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$108.87 - $125.09 $1.12 Million - $1.29 Million
10,320 New
10,320 $1.22 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.7B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.